Predicate |
Object |
contentType |
Journal Article |
endingPage |
9 |
issn |
1544-1873 1544-2241 |
issueIdentifier |
1 |
pageRange |
4-9 |
publicationName |
Current Osteoporosis Reports |
startingPage |
4 |
bibliographicCitation |
Maricic M. Intravenous zoledronic acid: what are the indications for male osteoporosis? Curr Osteoporos Rep. 2010 Mar;8(1):4–9. doi: 10.1007/s11914-010-0002-7. PMID: 20425084. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2963710f9ab6fa3daaef01313349eda3 |
date |
2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/20425084 https://doi.org/10.1007/s11914-010-0002-7 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32518 https://portal.issn.org/resource/ISSN/1544-2241 https://portal.issn.org/resource/ISSN/1544-1873 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Intravenous Zoledronic Acid: What Are the Indications for Male Osteoporosis? |
discusses |
http://id.nlm.nih.gov/mesh/M000603388 http://id.nlm.nih.gov/mesh/M0021196 http://id.nlm.nih.gov/mesh/M0028852 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0472480 http://id.nlm.nih.gov/mesh/M0020098 http://id.nlm.nih.gov/mesh/M0015931 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8026 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 |